Suppr超能文献

结直肠癌诊断的进展:分子生物标志物与成像技术的应用:文献综述

Advances in the diagnosis of colorectal cancer: the application of molecular biomarkers and imaging techniques: a literature review.

作者信息

Kwan Alicia Su Huey, Uwishema Olivier, Mshaymesh Sarah, Choudhary Karan, Salem Fatma K, Sengar Aman Singh, Patel Raj Pravin, Kazan Zeinab, Wellington Jack

机构信息

Department of Research and Education, Oli Health Magazine Organization, Research and Education, Kigali, Rwanda.

Department of Medicine for Older People, Southampton General Hospital, Southampton, United Kingdom.

出版信息

Ann Med Surg (Lond). 2025 Jan 9;87(1):192-203. doi: 10.1097/MS9.0000000000002830. eCollection 2025 Jan.

Abstract

BACKGROUND

Following neoplasms of the lung and breast, colorectal cancer (CRC) is the third most frequent malignancy globally. Screening for CRC at the age of 50 years is strongly encouraged for prompt earlier diagnosis owing to prognoses being greatly correlated with time of detection and cancer staging.

AIM

This review aimed to elucidate the most recent advancements in the detection of CRC, with an emphasis on the latest innovations in diagnostic molecular biomarkers in conjunction with radiological imaging alongside stool-based tests for CRC screening.

METHODS

A comprehensive review of the literature was performed, focusing on specific terms in different electronic databases, including that of PubMed/MEDLINE. Keywords pertaining to "colorectal cancer," "diagnosis," "screening," "imaging," and "biomarkers," among others, were employed in the search strategy. Articles screened and evaluated were deemed relevant to the study aim and were presented in the medium of the English language.

RESULTS

There have been several innovations in the diagnostics and identification of CRC. These generally comprise molecular biomarkers, currently being studied for suitability in disease detection. Examples of these include genetic, epigenetic, and protein biomarkers. Concurrently, recent developments in CRC diagnostics highlight the advancements made in radiological imaging that offer precise insights on tumor biology in addition to morphological information. Combining these with statistical methodologies will increase the sensitivity and specificity of CRC diagnostics. However, putting these strategies into reality is hampered by several issues.

CONCLUSION

Progress in diagnostic technology alongside the identification of a few prognostic predictive molecular biomarkers suggested great promise for prompt detection and management of CRC. This clearly necessitates further efforts to learn more in this specific sector.

摘要

背景

结直肠癌(CRC)是全球第三大常见恶性肿瘤,仅次于肺癌和乳腺癌。强烈建议50岁时进行CRC筛查,以便尽早诊断,因为预后与检测时间和癌症分期密切相关。

目的

本综述旨在阐明CRC检测的最新进展,重点关注诊断分子生物标志物的最新创新,以及结合放射影像学和基于粪便的CRC筛查检测。

方法

对文献进行全面综述,重点关注不同电子数据库中的特定术语,包括PubMed/MEDLINE。搜索策略中使用了与“结直肠癌”、“诊断”、“筛查”、“成像”和“生物标志物”等相关的关键词。筛选和评估的文章被认为与研究目的相关,并以英文发表。

结果

CRC的诊断和识别有多项创新。这些创新通常包括目前正在研究其在疾病检测中适用性的分子生物标志物。其中包括基因、表观遗传和蛋白质生物标志物。同时,CRC诊断的最新进展突出了放射影像学的进步,除了形态学信息外,还能提供有关肿瘤生物学的精确见解。将这些与统计方法相结合将提高CRC诊断的敏感性和特异性。然而,将这些策略付诸实践受到几个问题的阻碍。

结论

诊断技术的进步以及一些预后预测分子生物标志物的识别为CRC的早期检测和管理带来了巨大希望。这显然需要进一步努力,以便在这一特定领域了解更多信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f662/11918703/790e8fc25836/ms9-87-192-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验